We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
46 hedge funds and large institutions have $58.8M invested in ESSA Pharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
225% more call options, than puts
Call options by funds: $179K | Put options by funds: $55K
140% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 10
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
44% more funds holding
Funds holding: 32 → 46 (+14)
5.09% less ownership
Funds ownership: 79.11% → 74.03% (-5.1%)
72% less capital invested
Capital invested by funds: $213M → $58.8M (-$154M)
Holders
46
Holders Change
+14
Holders Change %
+43.75%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
24
Increased
8
Reduced
5
Closed
10
Calls
$179K
Puts
$55K
Net Calls
+$124K
Net Calls Change
+$228K
Top Buyers
Top Sellers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$47.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16.6M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.93M |
| 4 |
RI
RTW Investments
New York
|
-$6.84M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.45M |
